ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

57
Analysis
Health Care • Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
•11 Nov 2018 18:54

Japan: Moving Average Outliers - Results Driven

MOVING AVERAGE OUTLIERS - Our moving average outlier indicator uses a weighted sum of the share price relative to the 5-day, 20-day, 60-day, 120...

Logo
565 Views
Share
bullish•SanBio Co Ltd
•25 Oct 2018 17:03

Investment Thesis and Valuation

Key drivers / Concerns SanBio is a one drug company Key pipeline candidate, SB623 (allogeneic regenerative cell medicine for chronic motor deficit...

x